Attenuation of transforming growth factor-β-stimulated collagen production in fibroblasts by quercetin-induced heme oxygenase-1

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 5, 2011, Pages 614-620

  Nakamura, Toshinobu ^a   Matsushima, Miyoko ^b   Hayashi, Yuta ^a   Shibasaki, Masataka ^a   Imaizumi, Kazuyoshi ^a   Hashimoto, Naozumi ^a   Shimokata, Kaoru ^a   Hasegawa, Yoshinori ^a   Kawabe, Tsutomu ^b  

^a Graduate School of Medicine   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Collagen; Fibroblast; Heme oxygenase 1; Idiopathic pulmonary fibrosis; Quercetin

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; COLLAGEN; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE; QUERCETIN; SMAD PROTEIN; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; EMBRYO; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELL NUCLEUS; COLLAGEN; CYTOPLASM; ENZYME INHIBITORS; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NIH 3T3 CELLS; PULMONARY FIBROSIS; QUERCETIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 79955492201     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0338OC     Document Type: Article

References (33)

1. American Thoracic Society, European Respiratory Society. Joint statement: American Thoracic Society/European Respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
2. Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest 2009;136:1364-1370.
3. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151. (Pubitemid 32096342)
4. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement: American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
5. du Bois RM. Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov 2010;9:129-140.
6. Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005; 353:2229-2242. (Pubitemid 41697286)
7. Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010;35:821-829.
8. Maestrelli P, El Messlemani AH, De Fina O, Nowicki Y, Saetta M, Mapp C, Fabbri LM. Increased expression of heme oxygenase (HO)- 1 in alveolar spaces and HO-2 in alveolar walls of smokers. Am J Respir Crit Care Med 2001;164:1508-1513. (Pubitemid 33124035)
9. Horvath I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, Barnes PJ. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 1998;53:668-672. (Pubitemid 28378481)
10. Lee PJ, Alam J, Sylvester SL, Inamdar N, Otterbein L, Choi AM. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol 1996;14:556-568. (Pubitemid 126442947)
11. Zhou H, Lu F, Latham C, Zander DS, Visner GA. Heme oxygenase-1 expression in human lungs with cystic fibrosis and cytoprotective effects against Pseudomonas aeruginosa in vitro. Am J Respir Crit Care Med 2004;170:633-640. (Pubitemid 39202205)
12. Lu F, Zander DS, Visner GA. Increased expression of heme oxygenase- 1 in human lung transplantation. J Heart Lung Transplant 2002;21: 1120-1126. (Pubitemid 35190330)
13. Maestrelli P, Paska C, Saetta M, Turato G, Nowicki Y, Monti S, Formichi B, Miniati M, Fabbri LM. Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients. Eur Respir J 2003;21:971-976. (Pubitemid 36675612)
14. Matsushima M, Takagi K, Ogawa M, Hirose E, Ota Y, Abe F, Baba K, Hasegawa T, Hasegawa Y, Kawabe T. Heme oxygenase-1 mediates the anti-allergic actions of quercetin in rodent mast cells. Inflamm Res 2009;58:705-715.
15. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY, Jeong WI, Ryu SY, Do SH, Lee CS, et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 2003; 243:153-160.
16. Verma AK, Johnson JA, Gould MN, Tanner MA. Inhibition of 7,12- dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 1988;48: 5754-5758.
17. Lee ES, Lee HE, Shin JY, Yoon S, Moon JO. The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats. J Pharm Pharmacol 2003;55:1169-1174. (Pubitemid 36998660)
18. Chow JM, Shen SC, Huan SK, Lin HY, Chen YC. Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via antioxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol 2005;69:1839-1851. (Pubitemid 40780083)
19. Lin HC, Cheng TH, Chen YC, Juan SH. Mechanism of heme oxygenase -1 gene induction by quercetin in rat aortic smooth muscle cells. Pharmacology 2004;71:107-112.
20. Sumida A, Hasegawa Y, Okamoto M, Hashimoto N, Imaizumi K, Yatsuya H, Yokoi T, Takagi K, Shimokata K, Kawabe T. Th1/Th2 immune response in lung fibroblasts in interstitial lung disease. Arch Med Res 2008;39:503-510.
21. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008;585:325-337.
22. Phan TT, Lim IJ, Sun L, Chan SY, Bay BH, Tan EK, Lee ST. Quercetin inhibits fibronectin production by keloid-derived fibroblasts: implication for the treatment of excessive scars. J Dermatol Sci 2003;33:192-194. (Pubitemid 37485704)
23. Martinez JA, Ramos SG, Meirelles MS, Verceze AV, Arantes MR, Vannucchi H. Effects of quercetin on bleomycin-induced lung injury: a preliminary study. J Bras Pneumol 2008;34:445-452.
24. Yuan ZP, Chen LJ, Fan LY, Tang MH, Yang GL, Yang HS, Du XB, Wang GQ, Yao WX, Zhao QM, et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res 2006;12:3193-3199.
25. Baowen Q, Yulin Z, Xin W, Wenjing X, Hao Z, Zhizhi C, Xingmei D, Xia Z, Yuquan W, Lijuan C. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis. Eur J Pharmacol 2010;642:134-139.
26. Slebos DJ, Ryter SW, Choi AM. Heme oxygenase-1 and carbon monoxide in pulmonary medicine. Respir Res 2003;4:7.
27. Tsuburai T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Hasiba T, Ueda A, Ikehara K, Matsuse T, Ishigatsubo Y. Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lung prevents bleomycin-induced pulmonary fibrosis via a Fas-Fas ligandindependent pathway. Hum Gene Ther 2002;13:1945-1960. (Pubitemid 35341036)
28. Zhou Z, Song R, Fattman CL, Greenhill S, Alber S, Oury TD, Choi AM, Morse D. Carbon monoxide suppresses bleomycin-induced lung fibrosis. Am J Pathol 2005;166:27-37. (Pubitemid 40051657)
29. Yao P, Nussler A, Liu L, Hao L, Song F, Schirmeier A, Nussler N. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol 2007;47:253-261. (Pubitemid 47023137)
30. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, Cook JL. Nrf2, a cap'n'collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1999;274:26071-26078.
31. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002;99: 16093-16098. (Pubitemid 35462754)
32. Granado-Serrano AB, Martin MA, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/AKT and ERK pathways in a human hepatoma cell line (HepG2). J Nutr 2006;136:2715-2721. (Pubitemid 44771763)
33. Ishikawa Y, Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int 2000;58:1078-1087.